Candida fungi culture with antifungal sensitivity determination (urine, urethra, vagina, cervical canal, semen, prostate secretion, bile, CSF, pleural fluid, sputum, wound, throat/nasal/oral/ear/conjunctival swab, etc.)
Detects Candida yeast-like fungi in various biomaterials and determines antifungal sensitivity. Confirms fungal infection and helps select effective treatment.
Deviation mechanism: Candida fungi — opportunistic organisms on mucous membranes and skin; with immunity reduction or microflora disruption, actively proliferate → inflammation. Culture grows organism and determines antifungal sensitivity.
Recommended for: fungal infection signs; chronic, recurrent, or treatment-resistant inflammations; before antifungal therapy; treatment efficacy monitoring.
Urine, urethral/vaginal/cervical swab, semen, prostate secretion, bile, CSF, pleural fluid, sputum, wound discharge, throat/nasal/oral/ear/conjunctival swab, etc.
Depends on biomaterial type
Preferably collect before antifungal therapy
Inform physician of drug intake
Mucous membrane and skin inflammatory diseases; vaginal, urethral, oral candidiasis; frequent or prolonged urogenital infections; purulent wounds and burns; respiratory system problems; suspected systemic candidiasis; immunocompromised or post-antibiotic patients.
Candida fungi detected — fungal species and antifungal sensitivity listed.
Not detected — fungi not found.
Physician makes final assessment.
Note: Sensitivity testing only when clinically significant organism detected.
Recommended physicians: Urologist/Gynecologist (urogenital); Dermatologist (skin/mucosa); Pulmonologist (respiratory tract); General Practitioner.
